Charles Matine is a director of Bionik Laboratories Corp.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jun 23 | BNKL Bionik Laboratories | Common Stock, par value $0.001 per share | Buy | Acquire P | No | No | 0.6 | 180,555 | 108.33 k | 206,985 |